A First-in-Human Study to Evaluate the Safety and Tolerability of ALN-APP in Patients with EOAD

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508363-79-00

Acronym

ALN-APP-001

Enrollment

Registered

2024-02-05

Start date

2022-06-29

Completion date

Unknown

Last updated

2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-onset Alzheimer's disease (EOAD)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026